2014年度中美(NSFC-NIH)HIV/AIDS治疗研究合作项目初审结果公布

2015-01-21 小吴 整理 医学论坛网

2015年01月19日,国家自然科学基金委员会(NSFC)官方网站公布了2014年度中美(NSFC-NIH)HIV/AIDS治疗研究合作项目初审结果。据悉,2014年度NSFC与美国国立卫生研究院(NIH)HIV/AIDS治疗研究合作项目受理期间,共收到纸质项目申请24份,根据该项目指南的要求和NSFC关于项目初审的相关规定,确定有效申请16项。其中通过初审的项目如下:

2015年01月19日,国家自然科学基金委员会(NSFC)官方网站公布了2014年度中美(NSFC-NIH)HIV/AIDS治疗研究合作项目初审结果。据悉,2014年度NSFC与美国国立卫生研究院(NIH)HIV/AIDS治疗研究合作项目受理期间,共收到纸质项目申请24份,根据该项目指南的要求和NSFC关于项目初审的相关规定,确定有效申请16项。其中通过初审的项目如下:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
    2015-09-22 wjywjy
  2. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
    2015-07-19 xuyu
  5. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
    2015-01-23 cooco
  6. [GetPortalCommentsPageByObjectIdResponse(id=2033816, encodeId=ffe72033816e1, content=<a href='/topic/show?id=852b216824' target=_blank style='color:#2F92EE;'>#AID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2168, encryptionId=852b216824, topicName=AID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Tue Sep 22 21:37:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004359, encodeId=f5b42004359de, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78621, encryptionId=54ebe8621cf, topicName=结果公布)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat Nov 07 14:37:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992382, encodeId=456a1992382ce, content=<a href='/topic/show?id=764d322045a' target=_blank style='color:#2F92EE;'>#初审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32204, encryptionId=764d322045a, topicName=初审结果)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Sat Dec 05 13:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042098, encodeId=f11920420989b, content=<a href='/topic/show?id=b0db88910c' target=_blank style='color:#2F92EE;'>#HIV/AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8891, encryptionId=b0db88910c, topicName=HIV/AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Jul 19 14:37:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365609, encodeId=a842136560908, content=<a href='/topic/show?id=41fa21e036' target=_blank style='color:#2F92EE;'>#AIDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2170, encryptionId=41fa21e036, topicName=AIDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536904, encodeId=67d3153690495, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Fri Jan 23 00:37:00 CST 2015, time=2015-01-23, status=1, ipAttribution=)]
    2015-01-23 宋威

相关资讯

2014 HIV/AIDS 领域大事盘点

编者按:2014年,对于关注艾滋病毒/艾滋病(HIV/AIDS)医学领域的人来说,既有好消息又有坏消息:HIV重现打碎 “密西西比婴儿”治愈奇迹;包括前国际艾滋病协会主席乔普•朗格(Joep Lange)及其夫人在内的6名专家在马航MH17空难中丧生;美国与几个欧洲国家一起弄清了人类第一例艾滋病发生在何处,是何时以及如何发生的;HIV新感染者少于新获治疗者,全球

Nat Biotechnol:新型3D疫苗横扫癌症及艾滋病

癌症如此致命的一个原因是它可以逃避机体免疫系统的攻击,使得肿瘤能够旺盛生长及扩散。科学家们一直在设法尝试利用免疫疗法来诱导免疫系统进入到抗癌攻击模式,建立起对癌细胞的长期免疫抵抗。 现在,来自Wyss生物启发工程研究所和哈佛大学工程与应用科学学院的研究人员证实,非手术注射可在体内自发组装成3D结构的一些可编程生物材料,可以对抗甚至帮助预防癌症以及诸如艾滋病一类的传染病。他们的研究结果发表在《自然

Retrovirology:我国发现疟疾感染有利于HIV储存库清除

讯(记者徐平鸽)中国科学院广州生物医药与健康研究院陈小平研究组在对疟疾和艾滋病相互关系的研究中,建立了猴免疫缺陷病毒(SIV)和疟原虫共感染的恒河猴模型,以模拟人免疫缺陷病毒(HIV)和疟原虫的共感染。基于该动物模型的研究,发现在抗逆转录病毒治疗(ART)前提下,疟疾感染有利于SIV病毒储存库的清除,并初步阐述其机理。相关研究成果于近日发表在逆转录病毒学 (Retrovirology)杂志上,

艾滋病治疗再受挫 “柏林病人”奇迹未重现

“柏林病人”蒂莫西·布朗是公认迄今唯一被“治愈”的艾滋病患者。但他的主治医生本周报告说,给布朗使用的骨髓干细胞移植疗法在其他至少6名艾滋病患者身上全部失败,且6人全部很快死亡。 这是继“密西西比婴儿”体内重现艾滋病病毒后又一个令人失望的消息。 2007年,来自美国的布朗在德国柏林接受了一次骨髓干细胞移植治疗。骨髓捐赠者本身有一种罕见的基因突变,这种突变可使免疫细胞对艾滋病病毒产生抵

联合国就四川感染艾滋病儿童遭驱赶事件发声明

联合国声明: 包括儿童在内的所有艾滋病病毒感染者和受艾滋病影响的人们,享有和其他人一样的权利。 联合国系统十分关注四川省西充县感染艾滋病儿童的报道,该儿童受到了来自许多社区其他成员的歧视。 羞辱和歧视是我们在应对艾滋病战役中最大的敌人。所有形式和情境下的羞辱和歧视都是不可以接受的,并且必须要停止。没有理由从正常的生活中排斥艾滋病病毒感染者,无论成人还是儿童。但可悲的是,本周的

PNAS:HIV-1衣壳分解分子机制 助力艾滋病新型疗法开发

试想当一个行李箱在颠簸的旅途被碰开时,箱子中整理的衣服会洒落一地;而类似尴尬的事情就好比是你的手提箱在该打开的时候死活打不开。上述比喻说明了HIV-1衣壳对于HIV-1的重要性,衣壳是保护HIV-1的保护性“胶囊”,一旦病毒进入机体细胞中其必须分解,在合适的地点和合适的时间释放出病毒核酸。 近日,发表在国际杂志PNAS上的一篇研究论文中,来自美国德克萨斯大学健康科学中心的研究人员通过研究表示